Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops
Racial-ethnic inequity in type 1 diabetes technology use is well documented and contributes to disparities in glycemic and long-term outcomes. However, solutions to address technology inequity remain sparse and lack stakeholder input. We employed user-centered design principles to conduct workshop s...
Saved in:
Published in | Diabetes technology & therapeutics Vol. 24; no. 6; p. 381 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Racial-ethnic inequity in type 1 diabetes technology use is well documented and contributes to disparities in glycemic and long-term outcomes. However, solutions to address technology inequity remain sparse and lack stakeholder input.
We employed user-centered design principles to conduct workshop sessions with multidisciplinary panels of stakeholders, building off of our prior study highlighting patient-identified barriers and proposed solutions. Stakeholders were convened to review our prior findings and co-create interventions to increase technology use among underserved populations with type 1 diabetes. Stakeholders included type 1 diabetes patients who had recently onboarded to technology; endocrinology and primary care physicians; nurses; diabetes educators; psychologists; and community health workers. Sessions were recorded and analyzed iteratively by multiple coders for common themes.
We convened 7 virtual 2-h workshops for 32 stakeholders from 11 states in the United States. Patients and providers confirmed prior published studies highlighting patient barriers and generated new ideas by co-creating solutions. Common themes of proposed interventions included (1) prioritizing more equitable systems of offering technology, (2) using visual and hands-on approaches to increase accessibility of technology and education, (3) including peer and family support systems more, and (4) assisting with insurance navigation and social needs.
Our study furthers the field by providing stakeholder-endorsed intervention ideas that propose feasible changes at the patient, provider, and system levels to reduce inequity in diabetes technology use in type 1 diabetes. Multidisciplinary stakeholder engagement in disparities research offers unique insight that is impactful and acceptable to the target population. |
---|---|
AbstractList | Racial-ethnic inequity in type 1 diabetes technology use is well documented and contributes to disparities in glycemic and long-term outcomes. However, solutions to address technology inequity remain sparse and lack stakeholder input.
We employed user-centered design principles to conduct workshop sessions with multidisciplinary panels of stakeholders, building off of our prior study highlighting patient-identified barriers and proposed solutions. Stakeholders were convened to review our prior findings and co-create interventions to increase technology use among underserved populations with type 1 diabetes. Stakeholders included type 1 diabetes patients who had recently onboarded to technology; endocrinology and primary care physicians; nurses; diabetes educators; psychologists; and community health workers. Sessions were recorded and analyzed iteratively by multiple coders for common themes.
We convened 7 virtual 2-h workshops for 32 stakeholders from 11 states in the United States. Patients and providers confirmed prior published studies highlighting patient barriers and generated new ideas by co-creating solutions. Common themes of proposed interventions included (1) prioritizing more equitable systems of offering technology, (2) using visual and hands-on approaches to increase accessibility of technology and education, (3) including peer and family support systems more, and (4) assisting with insurance navigation and social needs.
Our study furthers the field by providing stakeholder-endorsed intervention ideas that propose feasible changes at the patient, provider, and system levels to reduce inequity in diabetes technology use in type 1 diabetes. Multidisciplinary stakeholder engagement in disparities research offers unique insight that is impactful and acceptable to the target population. |
Author | Leung, Stephanie L Finnan, Molly Agarwal, Shivani Park, Tina Long, Judith A McCurdy, Katie Gonzalez, Jeffrey S Crespo-Ramos, Gladys |
Author_xml | – sequence: 1 givenname: Shivani orcidid: 0000-0003-4506-3702 surname: Agarwal fullname: Agarwal, Shivani organization: NY-Regional Center for Diabetes Translation Research, Albert Einstein College of Medicine, Bronx, New York, USA – sequence: 2 givenname: Gladys surname: Crespo-Ramos fullname: Crespo-Ramos, Gladys organization: Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York, USA – sequence: 3 givenname: Stephanie L surname: Leung fullname: Leung, Stephanie L organization: Division of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA – sequence: 4 givenname: Molly surname: Finnan fullname: Finnan, Molly organization: Division of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA – sequence: 5 givenname: Tina surname: Park fullname: Park, Tina organization: Diagram LLC, New York, New York, USA – sequence: 6 givenname: Katie surname: McCurdy fullname: McCurdy, Katie organization: Diagram LLC, New York, New York, USA – sequence: 7 givenname: Jeffrey S surname: Gonzalez fullname: Gonzalez, Jeffrey S organization: Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York, USA – sequence: 8 givenname: Judith A surname: Long fullname: Long, Judith A organization: Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35138944$$D View this record in MEDLINE/PubMed |
BookMark | eNo9UMlOwzAUtBCILnDkivwDKX62s3GrylapCIm24lg58TM1TeMQO4d8BP9MK5bTjDSjmdGMyGntaiTkCtgEWJbfaKsmnHGYMJknJ2QIcZxGWZyLARl5_8EYSwWHczIQMYgsl3JIvpau6oJ1tafB0anWLXpP5zV-djb01Nb0zqoCA3q6wnJbu8q993Tt8Sit-gYp_Dtu6Sv6rgqemtbt6fOBWm19aZvK1qrt6TKoHW5dpbGlMxeVLapjNX1z7c5vXeMvyJlRlcfLXxyT9cP9avYULV4e57PpIiolxCHKUTMAI3Sap0InnEPGDKSCgTEgy0SXLDFGFhkIpeIiRcmFYDmTWpUJSMPH5Pont-mKPepN09r9YeDm7xf-DZnNZu0 |
CitedBy_id | crossref_primary_10_1210_endrev_bnac022 crossref_primary_10_1001_jamanetworkopen_2023_8881 crossref_primary_10_1210_clinem_dgad046 crossref_primary_10_1016_j_diabres_2024_111613 crossref_primary_10_1111_1753_0407_13401 crossref_primary_10_1016_j_eprac_2024_05_006 crossref_primary_10_1177_20420188241236289 crossref_primary_10_1016_j_ecl_2023_09_001 crossref_primary_10_1186_s12939_023_01976_6 crossref_primary_10_2337_dc22_0555 crossref_primary_10_1016_j_cct_2024_107493 crossref_primary_10_1016_j_ecl_2023_09_007 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/dia.2021.0496 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-8593 |
ExternalDocumentID | 35138944 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P30 DK020541 – fundername: NIDDK NIH HHS grantid: P30 DK111022 – fundername: NIDDK NIH HHS grantid: K23 DK115896 |
GroupedDBID | --- 0R~ 29F 34G 39C 4.4 53G 6PF AAWTL ABBKN ABJNI ACGFS ADBBV AENEX AHMBA ALMA_UNASSIGNED_HOLDINGS BNQNF CAG CGR COF CS3 CUY CVF DU5 EBS ECM EIF EJD F5P IAO IER IHR IM4 INH INR ITC MV1 NPM NQHIM O9- PQQKQ RIG RML UE5 |
ID | FETCH-LOGICAL-c415t-9ed011f3d7973d622180f17301ff14c6dc06ff4b813aa5b7e42330904dac614f2 |
IngestDate | Sat Nov 02 12:32:07 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Diabetes technology Inequity Disparities Type 1 diabetes Race–ethnicity Minority |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c415t-9ed011f3d7973d622180f17301ff14c6dc06ff4b813aa5b7e42330904dac614f2 |
ORCID | 0000-0003-4506-3702 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9208861 |
PMID | 35138944 |
ParticipantIDs | pubmed_primary_35138944 |
PublicationCentury | 2000 |
PublicationDate | 2022-06-01 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Diabetes technology & therapeutics |
PublicationTitleAlternate | Diabetes Technol Ther |
PublicationYear | 2022 |
SSID | ssj0007321 |
Score | 2.4518707 |
Snippet | Racial-ethnic inequity in type 1 diabetes technology use is well documented and contributes to disparities in glycemic and long-term outcomes. However,... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 381 |
SubjectTerms | Blood Glucose Diabetes Mellitus, Type 1 - therapy Humans Racial Groups Stakeholder Participation Technology United States |
Title | Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35138944 |
Volume | 24 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2IFW9VLzfyAdukZc4zpPbCigFsT1AV-qtimObrmiz201WCP4D_4ufxUzseNMWEHCJothZR55vPZ_H8yDkWQEq0RRcMCOSlMUm5axMlGQ611wVkudphfHO04N0fxa_O0qORqMfA6-ldSvH1bdfxpX8j1ThGcgVo2T_QbL-R-EB3IN84QoShutfydjbtJBBTpTqwj7e1vp8jdx6XgevesvqxoIezJouTwhuQAPue1jHuGZ92jY25KSLzL0Qswu89LPG0yq9gmWEebqJ9vbmZLFshkTXj9xuRkaUDeK9PJuffCpXX7rCA8HHEzyZmvuTkRW68LIP5Zn1BnxzWqqv_r332q1UnasaxsoH3pS9N69d5eUpVtMeGjdgX-ydsMbaLcgJaNHEVlHsV2wbde2QOVx-hS3_ckUthDlmVYU_3BgG4WPYFaXDfjDFy7MOIyLBg1ubkfLPrZeydPdNW2Qry7GEyAFajRwjyETEXX5X-JLnF75jh2z3717a2XQM5_AG2XVbEzqxOLtJRrq-RbanzvniNvnu4UbbBXVwoz3c6LymvdDpBm4U4IZNCDfKfY8X1IGNItjoFbDRAdjoAGzUg-0Ome29Pny5z1w1D1YBSWxZoRXoEiNUVmRCpRFwy9BwVDDG8LhKVRWmxsQy56IsE5lpIPoiLMJYlRVwSBPdJdfqRa3vE6qBxINerkQh4xj4faGMyaNSZxLUd8TlA3LPTuTx0qZsOe6n-OFvWx6RnQ0AH5PrBtYI_QQIZyufdtL8CSNWhzQ |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Solutions+to+Address+Inequity+in+Diabetes+Technology+Use+in+Type+1+Diabetes%3A+Results+from+Multidisciplinary+Stakeholder+Co-creation+Workshops&rft.jtitle=Diabetes+technology+%26+therapeutics&rft.au=Agarwal%2C+Shivani&rft.au=Crespo-Ramos%2C+Gladys&rft.au=Leung%2C+Stephanie+L&rft.au=Finnan%2C+Molly&rft.date=2022-06-01&rft.eissn=1557-8593&rft.volume=24&rft.issue=6&rft.spage=381&rft_id=info:doi/10.1089%2Fdia.2021.0496&rft_id=info%3Apmid%2F35138944&rft_id=info%3Apmid%2F35138944&rft.externalDocID=35138944 |